{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:32:05Z","timestamp":1789061525633,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23501-1","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T23:10:29Z","timestamp":1763075429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["New design peripheral defocus spectacle lens vs. single-vision for slowing myopia progression in children: randomized controlled trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Tamara","family":"Wygnanski-Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naava","family":"Gottesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Feit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Corcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Zvibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Stolovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"23501_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/vision6020020","volume":"6","author":"MM Carl\u00e0","year":"2022","unstructured":"Carl\u00e0, M. M. et al. Overview on defocus incorporated multiple segments lenses: a novel perspective in myopia progression management. Vision 6, 20 (2022).","journal-title":"Vision"},{"key":"23501_CR2","doi-asserted-by":"publisher","first-page":"1343698","DOI":"10.3389\/fphar.2024.1343698","volume":"15","author":"SH Lee","year":"2024","unstructured":"Lee, S. H., Tsai, P. C., Chiu, Y. C., Wang, J. H. & Chiu, C. J. Myopia progression after cessation of Atropine in children: a systematic review and meta-analysis. Front. Pharmacol. 15, 1343698 (2024).","journal-title":"Front. Pharmacol."},{"key":"23501_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden, B. A. et al. Global prevalence of myopia and high myopia and Temporal trends from 2000 through 2050. Ophthalmology 123, 1036\u20131042 (2016).","journal-title":"Ophthalmology"},{"key":"23501_CR4","doi-asserted-by":"crossref","unstructured":"Liang, J. et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J. Ophthalmol (2024).","DOI":"10.1136\/bjo-2024-325427"},{"key":"23501_CR5","doi-asserted-by":"publisher","first-page":"1125000","DOI":"10.3389\/fpubh.2023.1125000","volume":"11","author":"C Lanca","year":"2023","unstructured":"Lanca, C., Pang, C. P. & Grzybowski, A. Effectiveness of myopia control interventions: A systematic review of 12 randomized control trials published between 2019 and 2021. Front. Public. Heal. 11, 1125000 (2023).","journal-title":"Front. Public. Heal"},{"key":"23501_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","volume":"62","author":"IG Morgan","year":"2018","unstructured":"Morgan, I. G. et al. The epidemics of myopia: aetiology and prevention. Prog Retin Eye Res. 62, 134\u2013149 (2018).","journal-title":"Prog Retin Eye Res."},{"key":"23501_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/IAE.0000000000002590","volume":"40","author":"L Dong","year":"2020","unstructured":"Dong, L., Kang, Y. K., Li, Y., Wei, W. B. & Jonas, J. B. Prevalence and time trends of myopia in children and adolescents in china: a systemic review and meta-analysis. Retina 40, 399\u2013411 (2020).","journal-title":"Retina"},{"key":"23501_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.ophtha.2021.04.032","volume":"128","author":"MA Bullimore","year":"2021","unstructured":"Bullimore, M. A. et al. The risks and benefits of myopia control. Ophthalmology 128, 1561\u20131579 (2021).","journal-title":"Ophthalmology"},{"key":"23501_CR9","doi-asserted-by":"publisher","first-page":"881889","DOI":"10.3389\/fpubh.2022.881889","volume":"10","author":"S Keel","year":"2022","unstructured":"Keel, S. et al. The WHO-ITU myopiaed programme: a digital message programme targeting education on myopia and its prevention. Front. Public. Heal. 10, 881889 (2022).","journal-title":"Front. Public. Heal"},{"key":"23501_CR10","doi-asserted-by":"crossref","unstructured":"Lawrenson, J. G. et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst. Rev (2023).","DOI":"10.1002\/14651858.CD014758.pub2"},{"key":"23501_CR11","doi-asserted-by":"crossref","unstructured":"Laan, D.,  Tan, E. T. C. in het Veld, P. I. H., Jellema, H. M. & Jenniskens, K. Myopia progression in children during home confinement in the COVID-19 pandemic: A systematic review and meta-analysis. J. Optom. 17, 100493 (2024).","DOI":"10.1016\/j.optom.2023.100493"},{"key":"23501_CR12","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.18240\/ijo.2022.10.20","volume":"15","author":"JX Ma","year":"2022","unstructured":"Ma, J. X., Tian, S. W. & Liu, Q. P. Effectiveness of peripheral defocus spectacle lenses in myopia control: a Meta-analysis and systematic review. Int. J. Ophthalmol. 15, 1699 (2022).","journal-title":"Int. J. Ophthalmol."},{"key":"23501_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/ICU.0000000000000367","volume":"28","author":"SW Leo","year":"2017","unstructured":"Leo, S. W. Current approaches to myopia control. Curr. Opin. Ophthalmol. 28, 267\u2013275 (2017).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"23501_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.64.6.6","volume":"64","author":"JS Wolffsohn","year":"2023","unstructured":"Wolffsohn, J. S., Whayeb, Y., Logan, N. S. & Weng, R. IMI\u2014global trends in myopia management attitudes and strategies in clinical practice\u20142022 update. Invest. Ophthalmol. Vis. Sci. 64, 6 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR15","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.3390\/jcm10225462","volume":"10","author":"K Mori","year":"2021","unstructured":"Mori, K. et al. Effect of Violet light-transmitting eyeglasses on axial elongation in myopic children: a randomized controlled trial. J. Clin. Med. 10, 5462 (2021).","journal-title":"J. Clin. Med."},{"key":"23501_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","volume":"130","author":"J Dong","year":"2023","unstructured":"Dong, J., Zhu, Z., Xu, H. & He, M. Myopia control effect of repeated low-level red-light therapy in Chinese children: a randomized, double-blind, controlled clinical trial. Ophthalmology 130, 198\u2013204 (2023).","journal-title":"Ophthalmology"},{"key":"23501_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia, A. et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the treatment of myopia 2). Ophthalmology 119, 347\u2013354 (2012).","journal-title":"Ophthalmology"},{"key":"23501_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam, J. C. et al. Low-concentration Atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% Atropine eye drops in myopia control. Ophthalmology 126, 113\u2013124 (2019).","journal-title":"Ophthalmology"},{"key":"23501_CR19","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1167\/iovs.13-12527","volume":"54","author":"C Chen","year":"2013","unstructured":"Chen, C., Cheung, S. W. & Cho, P. Myopia control using toric orthokeratology (TO-SEE study). Invest. Ophthalmol. Vis. Sci. 54, 6510\u20136517 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR20","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho, P. & Cheung, S. W. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest. Ophthalmol. Vis. Sci. 53, 7077\u20137085 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/jcm13041157","volume":"13","author":"M Lupon","year":"2024","unstructured":"Lupon, M., Nolla, C. & Cardona, G. New designs of spectacle lenses for the control of myopia progression: A scoping review. J. Clin. Med. 13, 1157 (2024).","journal-title":"J. Clin. Med."},{"key":"23501_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2020.10834","volume":"324","author":"JJ Walline","year":"2020","unstructured":"Walline, J. J. et al. Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial. Jama 324, 571\u2013580 (2020).","journal-title":"Jama"},{"key":"23501_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/diseases12090222","volume":"12","author":"L Buzzonetti","year":"2024","unstructured":"Buzzonetti, L., Petroni, S., Federici, M., Valente, P. & Iarossi, G. Effectiveness of defocus incorporated multiple segments in slowing myopia progression in pediatric patients as a function of age: Three-Year Follow-Up. Diseases 12, 222 (2024).","journal-title":"Diseases"},{"key":"23501_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam, C. S. Y. et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br. J. Ophthalmol. 104, 363\u2013368 (2020).","journal-title":"Br. J. Ophthalmol."},{"key":"23501_CR25","first-page":"1110","volume":"106","author":"CSY Lam","year":"2022","unstructured":"Lam, C. S. Y. et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br. J. Ophthalmol. 106, 1110\u20131114 (2022).","journal-title":"Br. J. Ophthalmol."},{"key":"23501_CR26","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.1038\/s41598-023-32700-7","volume":"13","author":"CSY Lam","year":"2023","unstructured":"Lam, C. S. Y. et al. Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Sci. Rep. 13, 5475 (2023).","journal-title":"Sci. Rep."},{"key":"23501_CR27","doi-asserted-by":"publisher","first-page":"e0281816","DOI":"10.1371\/journal.pone.0281816","volume":"18","author":"P Nucci","year":"2023","unstructured":"Nucci, P. et al. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS\/atropine. PLoS One. 18, e0281816 (2023).","journal-title":"PLoS One"},{"key":"23501_CR28","doi-asserted-by":"crossref","unstructured":"Rappon, J. et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br J. Ophthalmol (2022).","DOI":"10.1136\/bjo-2021-321005"},{"key":"23501_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao, J. et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 140, 472\u2013478 (2022).","journal-title":"JAMA Ophthalmol."},{"key":"23501_CR30","first-page":"1171","volume":"106","author":"J Bao","year":"2022","unstructured":"Bao, J. et al. One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br. J. Ophthalmol. 106, 1171\u20131176 (2022).","journal-title":"Br. J. Ophthalmol."},{"key":"23501_CR31","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Myopia control efficacy of spectacle lenses with aspherical lenslets: results of a 3-year Follow-up study. Am J. Ophthalmol (2023).","DOI":"10.1016\/j.ajo.2023.03.030"},{"key":"23501_CR32","first-page":"2852","volume":"43","author":"MH Edwards","year":"2002","unstructured":"Edwards, M. H., Li, R. W., Lam, C. S., Lew, J. K. & Yu, B. S. The Hong Kong progressive lens myopia control study: study design and main findings. Invest. Ophthalmol. Vis. Sci. 43, 2852\u20132858 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR33","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1167\/iovs.02-0816","volume":"44","author":"J Gwiazda","year":"2003","unstructured":"Gwiazda, J. et al. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest. Ophthalmol. Vis. Sci. 44, 1492\u20131500 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR34","doi-asserted-by":"crossref","unstructured":"Group, C. of M. E. T. 2. S. G. for the P. E. D. I. Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria. Invest. Ophthalmol. Vis. Sci. 52, 2749\u20132757 (2011).","DOI":"10.1167\/iovs.10-6631"},{"key":"23501_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/OPX.0b013e3181ea19c7","volume":"87","author":"P Sankaridurg","year":"2010","unstructured":"Sankaridurg, P. et al. Spectacle lenses designed to reduce progression of myopia: 12-month results. Optom. Vis. Sci. Off Publ Am. Acad. Optom. 87, 631 (2010).","journal-title":"Optom. Vis. Sci. Off Publ Am. Acad. Optom."},{"key":"23501_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajo.2023.08.019","volume":"257","author":"Y Cohen","year":"2024","unstructured":"Cohen, Y. et al. Evaluating the effect of a myopia control spectacle lens among children in israel: 12-month results. Am. J. Ophthalmol. 257, 103\u2013112 (2024).","journal-title":"Am. J. Ophthalmol."},{"key":"23501_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/aos.15649","volume":"101","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. One-year myopia control efficacy of cylindrical annular refractive element spectacle lenses. Acta Ophthalmol. 101, 651\u2013657 (2023).","journal-title":"Acta Ophthalmol."},{"key":"23501_CR38","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1167\/iovs.11-7260","volume":"52","author":"P Sankaridurg","year":"2011","unstructured":"Sankaridurg, P. et al. Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one-year results. Invest. Ophthalmol. Vis. Sci. 52, 9362\u20139367 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/bjophthalmol-2013-303914","volume":"98","author":"CSY Lam","year":"2014","unstructured":"Lam, C. S. Y., Tang, W. C., Tse, D. Y. Y., Tang, Y. Y. & To, C. H. Defocus incorporated soft contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial. Br. J. Ophthalmol. 98, 40\u201345 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"23501_CR40","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","volume":"138","author":"S Wei","year":"2020","unstructured":"Wei, S. et al. Safety and efficacy of low-dose Atropine Eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial. JAMA Ophthalmol. 138, 1178\u20131184 (2020).","journal-title":"JAMA Ophthalmol."},{"key":"23501_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","volume":"96","author":"P Chamberlain","year":"2019","unstructured":"Chamberlain, P. et al. A 3-year randomized clinical trial of misight lenses for myopia control. Optom. Vis. Sci. 96, 556\u2013567 (2019).","journal-title":"Optom. Vis. Sci."},{"key":"23501_CR42","doi-asserted-by":"crossref","unstructured":"Lu, Y. et al. Diversified segmental defocus optimization lenses with and without Atropine for myopia prevention: A randomized clinical trial. JAMA Ophthalmol (2025).","DOI":"10.1001\/jamaophthalmol.2025.2072"},{"key":"23501_CR43","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1167\/iovs.07-0385","volume":"49","author":"S Hasebe","year":"2008","unstructured":"Hasebe, S. et al. Effect of progressive addition lenses on myopia progression in Japanese children: a prospective, randomized, double-masked, crossover trial. Invest. Ophthalmol. Vis. Sci. 49, 2781\u20132789 (2008).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR44","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1167\/iovs.12-11462","volume":"55","author":"S Hasebe","year":"2014","unstructured":"Hasebe, S., Jun, J. & Varnas, S. R. Myopia control with positively aspherized progressive addition lenses: a 2-year, multicenter, randomized, controlled trial. Invest. Ophthalmol. Vis. Sci. 55, 7177\u20137188 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR45","doi-asserted-by":"publisher","first-page":"e001499","DOI":"10.1136\/bmjophth-2023-001499","volume":"9","author":"P Domsa","year":"2024","unstructured":"Domsa, P. et al. Astigmatism and maternal myopia as important factors affecting success rate of DIMS lens treatment. BMJ Open. Ophthalmol. 9, e001499 (2024).","journal-title":"BMJ Open. Ophthalmol."},{"key":"23501_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","volume":"40","author":"Q Tan","year":"2020","unstructured":"Tan, Q. et al. One-year results of 0.01% Atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic Physiol. Opt. 40, 557\u2013566 (2020).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"23501_CR47","doi-asserted-by":"publisher","first-page":"22311","DOI":"10.1038\/s41598-022-25599-z","volume":"12","author":"Z Huang","year":"2022","unstructured":"Huang, Z., Chen, X. F., He, T., Tang, Y. & Du, C. X. Synergistic effects of defocus-incorporated multiple segments and Atropine in slowing the progression of myopia. Sci. Rep. 12, 22311 (2022).","journal-title":"Sci. Rep."},{"key":"23501_CR48","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ophtha.2023.01.007","volume":"130","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. The efficacy of defocus incorporated multiple segments lenses in slowing myopia progression: results from diverse clinical circumstances. Ophthalmology 130, 542\u2013550 (2023).","journal-title":"Ophthalmology"},{"key":"23501_CR49","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1167\/iovs.11-7769","volume":"53","author":"DA Berntsen","year":"2012","unstructured":"Berntsen, D. A., Sinnott, L. T., Mutti, D. O. & Zadnik, K. A randomized trial using progressive addition lenses to evaluate theories of myopia progression in children with a high lag of accommodation. Invest. Ophthalmol. Vis. Sci. 53, 640\u2013649 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"23501_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12886-024-03666-5","volume":"24","author":"B Neller","year":"2024","unstructured":"Neller, B. et al. Effect of defocus incorporated multiple segments (DIMS) spectacle lenses on myopia progression in children: a retrospective analysis in a German real-life clinical setting. BMC Ophthalmol. 24, 403 (2024).","journal-title":"BMC Ophthalmol."},{"key":"23501_CR51","doi-asserted-by":"crossref","unstructured":"Lembo, A., Schiavetti, I., Serafino, M., Caputo, R. & Nucci, P. Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectacles. BMJ Paediatr. Open 8, (2024).","DOI":"10.1136\/bmjpo-2024-003187"},{"key":"23501_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/opo.12045","volume":"33","author":"AN French","year":"2013","unstructured":"French, A. N., Morgan, I. G., Mitchell, P. & Rose, K. A. Patterns of myopigenic activities with age, gender and ethnicity in S Ydney schoolchildren. Ophthalmic Physiol. Opt. 33, 318\u2013328 (2013).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"23501_CR53","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1111\/aos.14980","volume":"100","author":"O P\u00e4rssinen","year":"2022","unstructured":"P\u00e4rssinen, O. & Kauppinen, M. Associations of near work time, watching TV, outdoors time, and parents\u2019 myopia with myopia among school children based on 38-year\u2010old historical data. Acta Ophthalmol. 100, e430\u2013e438 (2022).","journal-title":"Acta Ophthalmol."},{"key":"23501_CR54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/jamaophthalmol.2020.0412","volume":"138","author":"X Jiang","year":"2020","unstructured":"Jiang, X. et al. Association of parental myopia with higher risk of myopia among multiethnic children before school age. JAMA Ophthalmol. 138, 501\u2013509 (2020).","journal-title":"JAMA Ophthalmol."},{"key":"23501_CR55","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/opo.12305","volume":"36","author":"SYL Chua","year":"2016","unstructured":"Chua, S. Y. L. et al. Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children. Ophthalmic Physiol. Opt. 36, 388\u2013394 (2016).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"23501_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/j.jcrs.0000000000000690","volume":"48","author":"R Mont\u00e9s-Mic\u00f3","year":"2022","unstructured":"Mont\u00e9s-Mic\u00f3, R. Evaluation of 6 biometers based on different optical technologies. J. Cataract Refract. Surg. 48, 16\u201325 (2022).","journal-title":"J. Cataract Refract. Surg."},{"key":"23501_CR57","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1038\/s41598-020-59919-y","volume":"10","author":"X Liao","year":"2020","unstructured":"Liao, X., Peng, Y., Liu, B., Tan, Q. Q. & Lan, C. J. Agreement of ocular biometric measurements in young healthy eyes between iolmaster 700 and OA-2000. Sci. Rep. 10, 3134 (2020).","journal-title":"Sci. Rep."},{"key":"23501_CR58","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/opo.13216","volume":"43","author":"A Ticak","year":"2023","unstructured":"Ticak, A. et al. Quality of life after wearing multifocal contact lenses for myopia control for 2 weeks in the BLINK study. Ophthalmic Physiol. Opt. 43, 1491\u20131499 (2023).","journal-title":"Ophthalmic Physiol. Opt."},{"key":"23501_CR59","unstructured":"Donahue, S. P. et al. Procedures for the evaluation of the visual system by pediatricians. Pediatrics 137  (2016)."},{"key":"23501_CR60","doi-asserted-by":"crossref","unstructured":"Fitzmaurice, G. M., Laird, N. M. & Ware, J. H. Applied Longitudinal Analysis (Wiley, 2012).","DOI":"10.1002\/9781119513469"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23501-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23501-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23501-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:03:07Z","timestamp":1763078587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23501-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23501"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23501-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial was approved by the Sheba Medical Center\u2019s and the Assuta Medical Center\u2019s ethics committees prior to the beginning of the trial and conducted according to the applicable Good Clinical Practice and local regulatory requirements (ClinicalTrials.gov Identifier: NCT06553404; date of first registration: 11\/8\/2024; MOH Identifier: MOH_2022-11-09_012170, available at my.health.gov.il\/CliniTrials; date of first registration: 09\/11\/2022). Assent and informed consent were obtained from the children and both parents prior to participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"T.W.-J., S.S., N.G. and N.F. declare no competing interests. Y.C. and C.S. have consulted for Crystal Optic Industries Ltd., Acre, Israel and received compensation. O.Z. has received compensation as an employee of Crystal Optic Industries Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39861"}}